The Hidden Value of Onsite Monitoring
October 18, 2017 – Ellie Einolhayat, RN, a Lexitas monitor (clinical research associate) provides insight on the role onsite monitors have in identifying issues with protocol design and other challenges that come with successfully executing a clinical trial. To learn about this and more, please read the attached article published in the August 2017 edition of Clinical Researcher.
Additional Resources
Behind the Acquisition: Lexitas Pharma Services & Erie Retina Research
The Need for Speed: Why vertical integration is the key to streamlining complex retina clinical trials
Best Corrected Visual Acuity: Still the Gold Standard in Clinical Trials—But for How Long?
Octane Welcomes Lexitas Pharma Services as Newest Octane Preferred Advisor
Lexitas Pharma Services Announces the Acquisition of Erie Retina Research, CASExERIE and Element Erie
Lexitas and NAMSA Announce Strategic Partnership to Deliver End-to-End Ophthalmic Medical Device Development